Subcutaneous injection of abelacimab results in lower levels of free factor XI and significantly fewer bleeding events than rivaroxaban in patients with atrial fibrillation at moderate-to-high risk ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

CagriSema, which underperformed expectations in its first Phase 3 test, will be studied at different doses and for longer ...

Saint Louis University's School of Medicine has a long tradition of excellence in medical school, graduate medical education and graduate education. Established in 1836, the school has the distinction ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed investors and wiped $125 billion from ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Acute pulmonary embolism is rare during childhood and adolescence. The high pulmonary embolism-related fatality among ...